The pattern of activation of CD3+CD56+CD8+ cells was quite similar to that reported by our group and others for Treg, which have a peak during the second and third trimesters and declining at PP (35), which could reflect their possible implication in MS activity during pregnancy and PP. This evidence concerns the gene NCAM1 and myeloid sarcoma.